首页> 外文期刊>Iranian Journal of Parasitology. >Efficacy of Artemisinin Base Combination Therapy and Genetic Diversity of Plasmodium falciparum from Uncomplicated Malaria Falciparum Patient in District of Pesawaran, Province of Lampung, Indonesia
【24h】

Efficacy of Artemisinin Base Combination Therapy and Genetic Diversity of Plasmodium falciparum from Uncomplicated Malaria Falciparum Patient in District of Pesawaran, Province of Lampung, Indonesia

机译:在印度尼西亚南邦省省省帕萨瓦伦市区简单的疟原虫疟原虫疟原虫疗效治疗和遗传多样性疟原虫遗传多样性

获取原文
           

摘要

Background: Malaria is an infectious disease caused by Plasmodium sp., that still prevalence in some part of Indonesia. District of Pesawaran is one of malaria endemic area in the Province of Lampung. The purpose of this study was to evaluate the efficacy of the ACT treatment in the District of Pesawaran Province of Lampung, Indonesia from Dec 2012 to Jul 2013 and the genetic variation of the Plasmodium falciparum also studied. Methods: This study was observational analytic study of falciparum malaria patients treated with ACT and primaquine (DHP-PQ and AAQ-PQ) at Hanura Primary Health Centre (Puskesmas). DNA isolation was done with QIAmp DNA Mini Kit. Amplification of PfMDR1, MSP1, and MSP2 genes was done with appropriate forward and reverse primer and procedures optimized first. PCR Product of PfMDR1 gene was prepared for sequencing. Data analysis was done with MEGA 6 software. Results: The results of this research are DHP-PQ effectiveness was still wellness among falciparum malaria patients in District of Pesawaran, Province of Lampung, Indonesia. There is Singlenucleotide mutation of N86Y of PfMDR1 gene. The dominant alleles found are MAD20 and 3D7 alleles with Multiplicity of Infection (MOI) are low. Conclusion: Therapy of DHP-PQ as an antimalarial falciparum in Pesawaran District, Lampung, Indonesia is still good. The genetic variation found was the SNP on the N86Y PfMDR1 gene, with dominant allele MAD20 and 3D7.
机译:背景:疟疾是由疟原虫SP引起的传染病。,在印度尼西亚的某些部分仍然普遍存在。 Pesawaran区是兰普省内疟疾的地方之一。本研究的目的是评估来自2012年12月至2013年7月的印度尼西亚Pesawaran省帕萨瓦伦地区的动作治疗的疗效,并研究了疟原虫疟原虫的遗传变异。方法:本研究是在汉鲁达初级保健中心(Puskesmas)的Act和Primaquine(DHP-PQ和AAQ-PQ)治疗的恶性疟疾患者的观察分析研究。 DNA分离是用QIAMP DNA迷你试剂盒进行的。通过适当的前向和反向引物和第一次优化的程序进行PFMDR1,MSP1和MSP2基因的扩增。制备PFMDR1基因的PCR产物进行测序。数据分析是用Mega 6软件完成的。结果:该研究的结果是DHP-PQ PQ效果仍然是帕萨瓦兰区区疟原虫,印度尼西亚省省省省疟原虫患者的健康。 PFMDR1基因存在N86Y的单核苷酸突变。发现的主要等位基因是MAD20和3D7等位基因,具有多种感染(MOI)是低的。结论:DHP-PQ治疗DHP-PQ作为Pesawaran区的抗疟原体疟原虫,印度尼西亚仍然很好。发现的遗传变异是N86Y PFMDR1基因上的SNP,具有显性等位基因MAD20和3D7。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号